Evaluating the Impact of Novel Incretin Therapies on Cardiovascular Outcomes in Type 2 Diabetes: An Early Systematic Review

• Главные авторы: Teodor Salmen (Автор), Claudia-Gabriela Potcovaru (Автор), Ioana-Cristina Bica (Автор), Rosaria Vincenza Giglio (Автор), Angelo Maria Patti (Автор), Roxana-Adriana Stoica (Автор), Marcello Ciaccio (Автор), Mohamed El-Tanani (Автор), Andrej Janež (Автор), Manfredi Rizzo (Автор), Florentina Gherghiceanu (Автор), Anca Pantea Stoian (Автор)
• Формат: ‌
• Опубликовано: MDPI AG, 2024-10-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

<i>Background</i> This systematic review is registered with CRD42024507397 protocol number and aims to compare the known data about retatrutide on long-term cardiovascular (CV) protection with tirzepatide, an incretin with recent proven CV benefits. <i>Material and Methods</i>...